1. Home
  2. HLMN vs MYGN Comparison

HLMN vs MYGN Comparison

Compare HLMN & MYGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hillman Solutions Corp.

HLMN

Hillman Solutions Corp.

HOLD

Current Price

$8.13

Market Cap

1.6B

ML Signal

HOLD

Logo Myriad Genetics Inc.

MYGN

Myriad Genetics Inc.

HOLD

Current Price

$4.59

Market Cap

481.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLMN
MYGN
Founded
1964
1991
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
481.6M
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
HLMN
MYGN
Price
$8.13
$4.59
Analyst Decision
Strong Buy
Buy
Analyst Count
5
8
Target Price
$11.60
$7.64
AVG Volume (30 Days)
2.0M
1.6M
Earning Date
05-22-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
122.22
N/A
EPS
0.20
N/A
Revenue
$1,552,224,000.00
$771,400,000.00
Revenue This Year
$7.65
$7.19
Revenue Next Year
$4.79
$5.64
P/E Ratio
$40.28
N/A
Revenue Growth
5.41
2.33
52 Week Low
$6.63
$3.76
52 Week High
$10.85
$10.30

Technical Indicators

Market Signals
Indicator
HLMN
MYGN
Relative Strength Index (RSI) 36.10 40.01
Support Level $7.91 $3.93
Resistance Level $8.32 $5.63
Average True Range (ATR) 0.25 0.34
MACD 0.00 0.02
Stochastic Oscillator 27.22 16.43

Price Performance

Historical Comparison
HLMN
MYGN

About HLMN Hillman Solutions Corp.

Hillman Solutions Corp is a provider of hardware-related products and related merchandising services to retail markets in North America. The company sells its products to hardware stores, home centers, mass merchants, pet supply stores, and other retail outlets. Its product lines include thousands of small parts such as fasteners and related hardware items; threaded rod and metal shapes; keys and accessories; builder's hardware; personal protective equipment, such as gloves and eye-wear; and identification items, such as tags and letters, numbers, and signs. The segments of the company are Hardware and Protective Solutions, which is the key revenue-generating segment; Robotics and Digital Solutions; and Canada. It has a business presence in the U.S, Canada and Mexico.

About MYGN Myriad Genetics Inc.

Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.

Share on Social Networks: